John Radford - Research output - Research Explorer The University of Manchester

1 results

Filter

2017
Real World Experience With Brentuximab Vedotin in Relapsed/Refractory CD30 Positive Lymphoma: Outcomes in 33 Patients After Prolonged Follow-up At a Single UK Centre
Piddock, K., Atabani, S., Gibb, A., Bloor, A., Murray, J., Kulkarni, S., Illidge, T., Linton, K. & Radford, J., 27 Mar 2017.
Research output: Contribution to conference › Paper › peer-review

File
65 Downloads (Pure)